There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
The objective of the study was to assess the efficacy and safety of four fixed doses
of nateglinide compared with placebo in the treatment of patients with type 2 diabetes
with focus on the prandial state.